Related by context. All words. (Click for frequent words.) 71 #mmHg [001] 69 systolic dysfunction 69 left ventricular systolic 68 mmHg diastolic 68 mL/min/#.# m 2 67 Diastolic 67 ejection fraction 67 pulmonary capillary wedge 67 #.#mg/dL 67 mmHg systolic 67 mm Hg systolic 67 fractional shortening 67 #mm Hg 67 infarct size 67 ejection fractions 66 serum potassium 66 CK MB 66 #.#mmHg 66 binary restenosis 66 MACCE 66 mL/min/#.# m2 66 ejection fraction EF 66 diastolic blood pressures 66 Ejection Fraction 66 systolic function 65 leukocyte count 65 LVEF 65 calculated creatinine clearance 65 serum aminotransferase levels 65 #mmHg [002] 65 troponin T 65 natriuresis 65 serum urate 64 glomerular filtration 64 #.#/#.# mmHg [001] 64 serum urate levels 64 Diastolic pressure 64 ventricular ejection fraction 64 left ventricular ejection 64 mL kg 64 serum phosphorous 64 estimated glomerular filtration 64 glomerular filtration rate 64 creatinine ratio 64 aspartate aminotransferase 64 Left Ventricular Ejection Fraction 64 Index CDAI 64 atheroma volume 64 alanine aminotransferase 64 HBeAg seroconversion 64 glycated hemoglobin levels 64 ventricular dilation 63 morphometric vertebral fractures 63 gastric pH 63 aspartate aminotransferase AST 63 nondiabetic patients 63 Intraocular pressure 63 left ventricular diastolic 63 aminotransferases 63 normal ULN 63 serum creatinine levels 63 Systolic 63 lumbar spine BMD 63 statin monotherapy 63 mL sec 63 neutrophil counts 63 cerebral oxygen saturation 63 arterial oxygen saturation 63 PSA nadir 63 Cmax 63 hemoglobin Hb 63 PaO 2 63 contractile function 63 pulmonary arterial 63 QRS duration 63 p = NS 63 albumin excretion rate 63 Hb A1C 63 creatinine clearance 62 PASI scores 62 mcg QD 62 nmol liter 62 achieved ACR# 62 β blockers 62 sUA 62 urine albumin 62 -#.# mg dL [002] 62 lumbar spine bone 62 cardiovascular hospitalizations 62 ischemia driven 62 #mg/dl 62 serum prostate 62 echocardiographic parameters 62 left ventricular LV 62 hyperemia 62 moderate renal impairment 62 CR nPR 62 mediated dilation 62 serum phosphorus 62 Systolic blood pressure 62 lopinavir r arm 62 intima media thickness 62 specific antigen PSA 62 diastolic pressure 62 systolic diastolic blood 62 intact parathyroid hormone 62 oxycodone CR 62 mm Hg diastolic 62 HbA 1c 62 pg mL 62 serum potassium levels 61 MADRS score 61 systolic diastolic 61 coronary stenosis 61 lactate dehydrogenase 61 glycosylated hemoglobin HbA1c 61 dobutamine 61 baseline serum creatinine 61 CDAI score 61 pulmonary exacerbations 61 thickness IMT 61 alanine aminotransferase ALT 61 normal LLN 61 lipoprotein Lp 61 SUVmax 61 glycated hemoglobin 61 XIENCE V PROMUS Stent 61 pulmonary artery pressure 61 sUA levels 61 X ULN 61 #/#mmHg 61 ischemic cardiomyopathy 61 arterial thromboembolic events 61 partial thromboplastin 61 Crohn Disease Activity 61 mmol l 61 Systolic pressure 61 serum sodium 61 fasting plasma glucose FPG 61 CrCl 61 cerebral oxygenation 61 diastolic BP 61 Serum creatinine 61 urate lowering therapy 61 deep venous thromboses 61 severe neutropenia 61 macroalbuminuria 61 pCR 61 corrected QT interval 61 ventricular dilatation 61 activated partial thromboplastin 61 diastolic pressures 61 postintervention 61 #.#mmol L [002] 61 hemoglobin A1c HbA1c 61 diameter stenosis 61 glycated hemoglobin HbA1c 61 μg L 61 #.#/#.# mm Hg [003] 61 mEq L 61 BENICAR HCT 61 Hypotension 61 mIU ml 61 serum phosphate levels 61 Postoperatively 61 QRS width 61 oxyhemoglobin 61 gadolinium enhancing lesions 61 μmol L 61 β blocker 61 detrusor 61 pmol L 61 tissue oxygenation 61 TAXUS p value 61 HOMA IR 61 HbA 1c levels 61 symptomatic intracranial hemorrhage 61 mcg mL 61 serum uric acid 60 serum calcium levels 60 % Confidence Interval 60 g dl 60 thickness CIMT 60 elevated IOP 60 dysfunction LVSD 60 HbA1C levels 60 adjunctive placebo 60 serum cortisol 60 arteriolar 60 QTcF 60 mmHg 60 ipsilateral stroke 60 inotropic 60 serum glucose 60 afterload 60 ml min 60 reinfarction 60 hours postdose 60 Severity MSCS score 60 cerebral perfusion 60 hypoperfusion 60 mmol 60 blood urea nitrogen 60 left ventricular dysfunction 60 intravenous diuretics 60 protein excretion 60 oxygen saturation SpO2 60 hemoglobin A1c levels 60 microvessel density 60 fibrinolysis 60 stent binary restenosis 60 preserved ejection fraction 60 FEV1 forced expiratory 60 TURBT 60 Operative mortality 60 mU liter 60 min -1 60 tissue oxygen saturation 60 salivary flow 60 serum phosphate 60 hypophosphatemia 60 cardiac contractility 60 luminal diameter 60 plasma creatinine 60 plasma HCV RNA 60 creatine kinase MB 60 AUC0 60 urinary oxalate 60 gout flares 60 #.#ng/ml 60 LV dysfunction 60 sub maximal 60 baseline HbA1c 60 repeat paracentesis 60 NPH insulin 60 fasting triglycerides 60 LV ejection fraction 60 P = .# 60 periprocedural 60 subcutaneous infusion 60 QRS interval 60 IU ml 60 hip BMD 60 symptomatic VTE 60 SGPT 60 Postoperative 60 PSADT 60 hematological parameters 60 diastolic dysfunction 60 myocardial reperfusion 60 plasma urate 60 mcg BID 60 vasopressor 60 pT3 60 -#.# log# copies mL 60 neointimal hyperplasia 60 lowest tertile 60 ventricular remodeling 60 crossclamp 60 neutrophil count 60 Febrile neutropenia 60 Endothelial function 60 x ULN 60 Cardiopulmonary bypass 60 ventricular repolarization 60 ADCS CGIC 60 Ishak fibrosis score 60 ropivacaine 60 SpO 2 60 hypopneas 60 eosinophil count 60 REYATAZ r arm 60 mild renal insufficiency 60 normothermic 60 μg liter 59 myocardial infarct 59 6MWD 59 mg/m2 dose 59 FOLFOX6 59 distensibility 59 urinary N telopeptide 59 serum triglycerides 59 ID TLR 59 urinary albumin 59 sinus tachycardia 59 recurrent VTE 59 refractory ischemia 59 Fasting blood glucose 59 postprocedure 59 plus methotrexate 59 thrombus formation 59 cardiac dysfunction 59 serum testosterone 59 preintervention 59 abdominal circumference 59 perioperative mortality 59 alanine transaminase 59 BENICAR 59 HbA1c levels 59 varices 59 MIC# [001] 59 creatine kinase 59 Target Lesion Revascularization TLR 59 postoperative morbidity 59 serum calcium 59 bypass grafting 59 ALT elevation 59 Left ventricular ejection 59 μg dL 59 cTnI 59 angiographic restenosis 59 elevated ALT 59 expiratory 59 systemic embolism 59 intravesical therapy 59 elevated transaminases 59 cytopenias 59 log# copies mL 59 SGOT 59 antibody titer 59 hemodilution 59 Creatinine 59 cTnT levels 59 Pharmacokinetic parameters 59 colorectal adenoma 59 pericardial effusion 59 lactate dehydrogenase LDH 59 systolic BP 59 exhaled NO 59 ug ml 59 locoregional recurrence 59 SCr 59 Infusion Reactions Severe 59 severe exacerbations 59 excess blasts RAEB 59 parenchymal 59 stenotic 59 aminotransferase ALT 59 nonfatal MI 59 hypokalemia 59 HER2 expression 59 Tumor shrinkage 59 pulmonary artery banding 59 asymptomatic carotid stenosis 59 NYHA class 59 postoperative hemorrhage 59 preoperative PSA 59 tertile 59 nonfatal myocardial infarction 59 4mg/kg 59 nonfasting triglyceride levels 59 postoperative complication 59 transaminase elevations greater 59 #Gy 59 DAS# remission 59 Erythropoietic therapies may 59 tirofiban 59 postdose 59 salmeterol fluticasone 59 mucosal healing 59 mL min 59 severe renal impairment 59 elevated LDH 59 elevated creatinine 59 serum CRP 59 QTc intervals 59 eplerenone 59 methemoglobin 59 nadolol 59 intraocular pressure IOP 59 biochemical relapse 59 unresectable HCC 59 Hazard Ratio HR 59 NYHA functional class 59 serum magnesium 59 CIMZIA TM 59 metoprolol tartrate 58 intima media thickness IMT 58 IOP lowering 58 Severe hypoglycemia 58 ng dL 58 urinary albumin excretion 58 myocardial infarction ventricular fibrillation 58 thoracoabdominal 58 rFVIIa 58 mmol liter 58 hsCRP levels 58 occluded catheters 58 cerebrovascular events 58 plasma lipids 58 sodium excretion 58 subtrochanteric 58 urinary sodium excretion 58 CK # plasma concentrations 58 neutropenia thrombocytopenia 58 aminotransferase levels 58 QT intervals 58 mercury mm Hg 58 inspiratory 58 mcg kg 58 fibrin deposition 58 pretreatment baseline 58 carotid artery intima media 58 dorsalis pedis 58 % AST SGOT 58 Forced expiratory volume 58 NYHA Class III 58 ‰ ¥ 58 test OGTT 58 target lesion revascularization 58 interquartile range 58 dyssynchrony 58 angina chest 58 transaminases 58 benazepril 58 serum lipid levels 58 reintubation 58 atrioventricular block 58 carotid IMT 58 cm H2O 58 EDSS score 58 umol L 58 leukocyte counts 58 undergoing coronary artery 58 #mg/day [002] 58 serum HBV DNA 58 atrioventricular valve 58 ventricular dysfunction 58 mucosal inflammation 58 diastolic function 58 alteplase 58 carotid intima media 58 systemic hypotension 58 PLX STROKE targeting 58 baseline FEV 58 rebleeding 58 lumen diameter 58 progression TTP 58 -#.# mmHg 58 biochemical recurrence 58 sweat chloride 58 mIU L 58 flow mediated dilation 58 NMIBC 58 highest tertile 58 hypovolemic 58 hepatic enzymes 58 nonvertebral fracture 58 OPCAB 58 somnolence headache 58 NNT = 58 PRADAXA #mg 58 oral allopurinol 58 oxygen desaturation 58 endometrial thickness 58 shortens systolic ejection 58 CCyR 58 Index CDAI score 58 -#.# mg dL [001] 58 dose corticosteroids 58 ventricular tachyarrhythmia 58 plasma triglycerides 58 vertebrobasilar 58 thrombocytopenic 58 Diastolic blood pressure 58 RYGB 58 myocardial contractility 58 hypervolemic 58 p = #.# [003] 58 SGRQ 58 A1c levels 58 hepatocellular 58 ischemic lesions 58 -#.# ± [002] 58 Ejection fraction 58 CVD mortality 58 statistical significance p 58 phonophobia 58 FDG uptake 58 detectable HCV RNA 58 octreotide LAR 58 arterial occlusion 58 aortic crossclamp 58 paroxysmal AF 58 8mg/kg 58 Triglyceride levels 58 erythrocyte sedimentation rate 58 serum triglyceride levels 58 Montgomery Asberg Depression 58 pg ml 58 chemoradiation therapy 58 events MACE 58 left ventricular hypertrophy 58 locoregional disease 58 -#.# log# 58 atherogenic dyslipidemia 58 systemic corticosteroid 58 elevated lipase 58 pulmonary exacerbation 58 hematologic toxicity 58 cholesterol LDL C 58 revascularizations 58 micromolar 58 irregular quivering 58 acutely decompensated congestive heart 58 peritumoral 58 triglyceride TG 58 reintervention 58 International Prostate Symptom 58 NIHSS 58 thromboembolic 58 PREZISTA r arm 58 uM 58 symptomatic intracranial 58 μg mL 58 QTc 58 μg ml 58 segment binary restenosis 58 log# reduction 58 nephrotoxicity 58 waist girth 58 nausea photophobia 58 anastomotic leak 58 nodular partial response 58 mean baseline HbA1c 58 baseline Hb 58 perioperatively 58 Scale EDSS score 58 postoperative mortality 58 IU mL 58 stent stenosis 57 hemodynamic parameters 57 Oral corticosteroids 57 abnormal p# biomarker 57 Primary endpoints 57 nicardipine 57 hyperphenylalaninemia HPA due 57 NYHA Class II 57 postoperative bleeding 57 systolic ejection 57 IIIa inhibitor 57 severe renal insufficiency 57 baseline A1C 57 recurrent atrial fibrillation 57 calcified plaques 57 LANTUS R 57 % CI #.#-#.# [003] 57 certolizumab 57 RECIST Response Evaluation Criteria 57 permanently discontinue Vectibix 57 secondary efficacy endpoint 57 #mg/dL [002] 57 hemoglobin A1C 57 NATRECOR ® 57 baseline FEV1 57 NovoLog ® Mix 57 recurrent ischemia 57 wedge resection 57 neurologic progression 57 serum LDL cholesterol 57 rosuvastatin #mg 57 mg/m2/day 57 creatinine levels 57 plasma renin activity 57 hemodynamically significant 57 mitomycin C 57 hypercapnia 57 titrated glipizide 57 plasma cortisol 57 lymphopenia 57 euvolemic 57 CI -#.# 57 carotid stenosis 57 baseline LDH 57 annualized relapse 57 urinary protein 57 serum creatinine 57 ATACAND 57 FEV1 57 ALND 57 xanthine oxidase inhibitor 57 zoledronate 57 Events MACE 57 thyroglobulin 57 Scale EDSS 57 intimal hyperplasia 57 mCi 57 HbA1C 57 Lupuzor ™ 57 iPTH 57 abacavir lamivudine 57 blood Phe 57 HDRS 57 fasting plasma glucose 57 systemic corticosteroids 57 Acetate Rectal Suppositories 57 reactive hyperemia 57 PSA kinetics 57 sternal wound infection 57 CK # plasma 57 mm3 57 #mg/dL [001] 57 bypass graft CABG surgery 57 ventricular enlargement 57 mg TID 57 tolterodine ER 57 coronary artery occlusion 57 per deciliter mg 57 myeloperoxidase 57 serum HCV RNA 57 steroid dexamethasone 57 plasma glucose levels 57 plasma renin 57 candesartan cilexetil 57 pulsatile flow 57 Secondary endpoints 57 pulmonary dysfunction 57 myocardial infarction stroke 57 carotid artery blockage 57 mmHg p = 57 radical nephrectomy 57 receiving prophylactic anticoagulation 57 residual platelet reactivity 57 bivalirudin monotherapy 57 microvascular complications 57 isoenzyme 57 #mg dose [002] 57 electrical cardioversion 57 renal dysfunction 57 paresthesias 57 thyrotropin 57 primary patency 57 baroreflex sensitivity 57 sinus node dysfunction 57 REMICADE monotherapy 57 CDAI 57 PEGylated anti 57 Calcium intake 57 Endothelial dysfunction 57 generalized edema 57 atorvastatin #mg 57 otamixaban 57 interleukin IL -6 57 silent ischemia 57 budesonide pMDI 57 5-FU/LV 57 clinically meaningful improvement 57 sustained virological response 57 systolic 57 macrovascular events 57 saline placebo 57 8 OHdG 57 A1C levels 57 elevated serum creatinine 57 non valvular atrial 57 Secondary endpoints include 57 platelet inhibition 57 nmol 57 serum parathyroid hormone 57 anemia hemoglobin 57 leukocytosis 57 TAXUS Liberte Long 57 mineral density 57 BPH Symptom Score 57 oral antidiabetic medication 57 relapsed MM 57 procalcitonin 57 CIMZIA ™ 57 FOLFOX4 57 ml kg 57 venous reflux 57 mg simvastatin 57 echocardiographic 57 QTc interval 57 #μg [001] 57 HBV DNA levels 57 hepatorenal syndrome 57 Unified Parkinson Disease 57 albuminuria 57 APTIVUS r 57 serum ferritin 57 dimensional echocardiography 57 ventricular dyssynchrony 57 recurrent venous thromboembolism 57 malignancy HCM 57 aneurysm sac 57 Tasigna prolongs 57 constipating effects 57 angiographic outcomes 57 cTnT 57 cells uL 57 UPDRS motor 57 confidence intervals CIs 57 lymphocytosis 57 hemodynamic variables 57 EDSS scores 57 vitreous floaters 57 liver histology 57 oxycodone IR 57 prolonged QT interval 57 oral antidiabetes 57 normoxic 57 aldosterone antagonist 57 peak VO2 57 #mg/m# [001] 57 myocardial oxygen 57 reoperations 57 diastolic readings 57 brain parenchyma 57 UACR 57 leucopenia 57 mitral regurgitation MR 57 microvolts 57 intraocular inflammation 57 intravitreal injections 57 nitroprusside 57 #ng/ml 57 transaminase elevations 57 hemorrhagic complications 57 prednisone prednisolone 57 leukopenia 57 cerebrovascular accident 57 salmeterol fluticasone propionate 57 timepoints 57 angioplasty stenting 57 kg -1 57 triglyceride concentrations 57 moderate hepatic impairment 57 WOMAC pain 57 IFN alfa 57 hepatectomy 57 fatal myocardial infarction 57 corticosteroid dose 57 diastolic hypertension 57 urinary excretion 56 AST ALT 56 deciliter 56 pyrexia mucositis sepsis febrile 56 myocardial ischemia 56 tertiles 56 PCWP 56 Solid Tumors criteria 56 placebo p = 56 SHBG levels 56 statistically significant p = 56 graft occlusion 56 expiratory flow 56 RVOT 56 elevated hsCRP 56 anticoagulant medications 56 mEq 56 plasma glucose 56 cardiovascular hospitalization 56 serum PTH 56 Taxus Stent 56 hypoxemia 56 intermittent hemodialysis 56 Skin sterol 56 #mg doses [002] 56 platelet activation 56 fluticasone salmeterol 56 serum bilirubin 56 DAS# [002] 56 thromboembolic complications 56 platelet reactivity 56 Doxil ® 56 colectomy 56 Available Seat Kilometres ASKs 56 circulating lymphocytes 56 transthoracic 56 H2RAs 56 mineral density BMD 56 low dose Iluvien 56 serum PSA 56 airflow obstruction 56 intravascular hemolysis 56 Q2W 56 Score IPSS 56 autoregulation 56 stage IIIb IV 56 TAXUS Liberté stent 56 angiotensin converting enzyme 56 radiotherapy RT 56 angiotensin converting enzyme ACE 56 cerebral vasospasm 56 peri procedural 56 thromboembolic events 56 pneumonectomy 56 Myoglobin 56 Patency 56 prospectively stratified 56 rCBF 56 bone marrow reticulin 56 serum concentrations 56 nmol l 56 composite endpoint 56 nonfatal stroke 56 chlorambucil 56 #mg/kg [002] 56 advanced adenoma 56 sievert 56 neutropenia dehydration dyspnea 56 MMSE score 56 serum sodium concentration 56 urinary cortisol 56 retinal thickness 56 inotropes 56 Mitral regurgitation 56 resuscitated cardiac arrest 56 Pain Intensity 56 haematologic 56 XIENCE V demonstrated 56 target vessel revascularization 56 cardiopulmonary bypass CPB 56 diuresis 56 estramustine 56 lymphocyte counts 56 occlusive disease 56 hypovolemia 56 blood oxygen saturation 56 R0 resection 56 elevated triglyceride levels 56 neutropaenia 56 contractility 56 ketorolac 56 VT VF 56 mg BID dose 56 % CI #.#-#.# [007] 56 ACR# responses 56 perioperative complications 56 intrathoracic 56 eGFR 56 evaluable subjects 56 plasma concentrations 56 complete cytogenetic response 56 bi ventricular pacing 56 oxygen saturations 56 #mg/m# [002] 56 BMI ≥ 56 mg hydrochlorothiazide 56 LVSD 56 Insulin sensitivity 56 rate variability HRV 56 response CCyR 56 sinus bradycardia 56 Zometa hazard 56 thrombotic complications 56 LDL cholesterol HDL cholesterol 56 anticoagulants blood thinners 56 Plasma concentrations 56 arteriography 56 #mg BID [003] 56 pericardial fat 56 gastric acid secretion 56 umbilical vein 56 bioavailable testosterone 56 tapentadol ER 56 patients undergoing CABG 56 IIIa inhibitors 56 CR CRu 56 unstable angina pectoris 56 underwent resection 56 clodronate 56 bronchodilation 56 ribavirin therapy 56 Flu Cy 56 lispro 56 N telopeptide 56 â ‰ ¥ 56 hemoptysis 56 trough FEV1 56 plasma fibrinogen 56 Postoperative complications 56 cGy 56 submaximal 56 transurethral resection 56 IBDQ 56 triglycerides TG 56 RBC transfusions 56 foveal thickness 56 aortic annulus 56 transferrin saturation 56 FFNS 56 achieved statistical significance 56 ACE Inhibitor 56 spinal cord compression 56 vascular reactivity 56 upper gastrointestinal bleeding 56 OGTT 56 Non inferiority 56 autonomic dysfunction 56 mitral stenosis 56 discontinuations due 56 nonfasting triglycerides 56 biphasic insulin aspart 56 total cholesterol triglycerides 56 GH secretion 56 lymphocyte count 56 Viral load 56 #mg BID [001] 56 dysuria 56 prednisone prednisolone plus 56 oocytes retrieved 56 bronchial hyperresponsiveness 56 postop 56 mg kg dose 56 brachial artery 56 isoprostane 56 irbesartan 56 paraprotein 56 graft patency 56 conjunctival hyperemia 56 g dL 56 metformin monotherapy 56 abdominal pain flatulence 56 q#h 56 dapagliflozin plus 56 albumin excretion 56 virologic breakthrough 56 Hgb 56 mm Hg 56 mcg ml 56 corneal curvature 56 paricalcitol 56 myocardial necrosis 56 ACR# response 56 neutropenic fever 56 atrial pacing 56 prolactin levels 56 mg BID 56 mmol L. 56 % CI #.#-#.# [001] 56 nonfatal myocardial infarction MI 56 non splenectomized 56 transaminase levels 56 baseline neutrophil counts 56 mercury mmHg 56 femoral shaft fracture 56 renal tubular 56 orthostatic hypotension 56 inotropic agents 56 thrombocytosis 56 hyperalgesia 56 pulmonary artery pressures 56 vasodilatation 56 hemodynamics 56 angiotensin II receptor blockers 56 histological subtype 56 autoantibody levels 56 metastatic GIST 56 residual stenosis 56 FluCAM arm 56 GI toxicity 56 pyridostigmine 56 Stent thrombosis 56 microg 56 adrenalectomy 56 comparator arm 56 ventricular mass 56 C Reactive Protein 56 cerebral ischemia 56 endoscopic remission 56 #.#mg/kg [002] 56 XP# Transported Prodrug 56 nmol L 56 DAS# CRP 56 mg tid 56 serum IGF 56 thyrotropin levels 56 posttreatment 56 CTEPH 56 keloid scarring 56 hyperintensity 56 Cystectomy 56 mg qd 56 blood lactate 56 beta blocker therapy 56 graft dysfunction 56 hyperkalemia 56 intracerebral 56 hydroxymethyl coenzyme 56 CABG coronary artery 56 CI #.#-#.# [001] 56 ALT flares 56 hemodynamic instability 56 postoperative AF 56 bezafibrate 56 intratumoral 56 lobectomy 56 macular thickness 56 purpura ITP 56 mmol L 56 F FDG uptake 56 systolic blood pressures 56 fatty infiltration 56 cinacalcet 56 TAXUS Stent 56 Key secondary endpoints 56 acromegalic patients